Z Israelian, NR Gosmanov, E Szoke, M Schorr, S … - Diabetes Care, 2005 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Twelve subjects with type 2 diabetes who have been
insulin requiring were studied as a model of advanced β-cell failure. Glucagon responses were
examined during a 90-min hypoglycemic clamp (∼2.8 mmol/l) on two separate ... Cited by 14 - Related articles - BL Direct - All 5 versions
- ►diabetesjournals.org NR Gosmanov, E Szoke, Z Israelian, T Smith, PE … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—During the 2nd h of the insulin infusion, when somatostatin or saline was no longer
being infused, plasma glucose (∼2.6 mmol/l) and insulin levels (∼570 pmol/l) were comparable
in both sets of experiments (both P > 0.4). In the saline experiments, insulin secretion ... Cited by 27 - Related articles - All 5 versions
[CITATION] The effect of hypoglycaemia unawareness on brain glucose content, transport and …
EM Bingham, J Dunn, J Sutcliffe-Goulden, P Marsden, … - Diabetologia, 2004 Cited by 3 - Related articles
- ►diabetesjournals.org SM Sherck, M Shiota, J Saccomando, S Cardin, EJ … - Diabetes, 2001 - Am Diabetes Assoc Mild non–insulin-induced hypoglycemia achieved by administration of a glycogen phosphorylase
inhibitor results in increased glucagon and decreased insulin secretion in conscious dogs. Our
aim was to determine whether the response of the endocrine pancreas to this mild ... Cited by 9 - Related articles - BL Direct - All 4 versions
BV Wiethop, PE Cryer - Diabetes care, 1993 - Am Diabetes Assoc OBJECTIVE--To test the hypothesis that the amino acid Ala and the beta 2-adrenergic agonist
terbutaline raise plasma glucose concentrations substantially, and do so through different
mechanisms, in IDDM patients. RESEARCH DESIGN AND METHODS--We administered ... Cited by 17 - Related articles - BL Direct - All 5 versions
[CITATION] Glucocorticoid insufficiency in corticotropin releasing hormone knockout mice does …
- ►diabetesjournals.org BE Levin, VH Routh, L Kang, NM Sanders, AA Dunn- … - Diabetes, 2004 - Am Diabetes Assoc Glucosensing neurons are specialized cells that use glucose as a signaling molecule to alter
their action potential frequency in response to variations in ambient glucose levels. Glucokinase
(GK) appears to be the primary regulator of most neuronal glucosensing, but other ... Cited by 2 - Related articles - All 2 versions
[CITATION] 2-adrenergic sensitivity is not reduced in type 1 diabetic patients with …
